Frazier Life Sciences Public Fund, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Trevi Therapeutics, Inc. Common Stock (TRVI)

Filing manager
Frazier Life Sciences Public Fund, L.P.
Reporting owner
James N. Topper
Security
Trevi Therapeutics, Inc. Common Stock
Beneficially owned shares
10,664,774 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

12%

Beneficial ownership of this reported class.

Shares

10,664,774 shares

Shares beneficially owned as disclosed.

Event date

31 Dec 2024

Date tied to the ownership event or amendment.

Accepted by SEC

14 Feb 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
12%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
TRVI
Shares outstanding
89,619,950 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
14 Feb 2025, 11:21:13 UTC
Event date
31 Dec 2024
Next SEC filing
15 May 2025
Source filing
View source filing

Key filing fact

Frazier Life Sciences Public Fund, L.P. disclosed 12% ownership in Trevi Therapeutics, Inc. Common Stock (TRVI) on 31 Dec 2024.

Key facts

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Trevi Therapeutics, Inc. Common Stock (TRVI).
  • Disclosed ownership: 12%.
  • Date of event: 31 Dec 2024.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 11:21.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (14)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 9.9% 8,819,620 0 8,819,620 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
FHMLSP, L.P. 9.9% 8,819,620 0 8,819,620 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
FHMLSP, L.L.C. 9.9% 8,819,620 0 8,819,620 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C.
Frazier Life Sciences X, L.P. 0.5% 428,000 0 428,000 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
FHMLS X, L.P. 0.5% 428,000 0 428,000 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
FHMLS X, L.L.C. 0.5% 428,000 0 428,000 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C.
Frazier Life Sciences XI, L.P. 1.6% 1,417,154 0 1,417,154 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
FHMLS XI, L.P. 1.6% 1,417,154 0 1,417,154 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
FHMLS XI, L.L.C. 1.6% 1,417,154 0 1,417,154 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
James N. Topper 12% 10,664,774 0 10,664,774 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Patrick J. Heron 12% 10,664,774 0 10,664,774 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Albert Cha 9.9% 8,819,620 0 8,819,620 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
James Brush 9.9% 8,819,620 0 8,819,620 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
Daniel Estes 1.6% 1,417,154 0 1,417,154 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .